S 8038 New York Senate · 2023 Regular Session

Relates to adverse determinations related to a step therapy protocol override determination; repealer

Summary
Requires written notice of an adverse determination made by a utilization review agent in relation to a step therapy protocol override determination which includes the clinical review criteria relied upon to make such determination and any applicable alternative prescription drugs subject to the step therapy protocol of the utilization review agent.
Bill status in committee 3 of 5 stages cleared
Introduction
Jan 2024
Committee Review
Jan 2024
Senate Passage
Jan 2024
Assembly Passage
Governor
Introduced Jan 5, 2024 Last action Jan 29, 2024
Floor votes · Senate Jan 8, 2024

How they voted

21–0
Passed
Total votes 21
Jan 8, 2024
D Democratic14
14 Yea
100% Yea
R Republican7
7 Yea
100% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
4
Key actions
1
Committee
1
Jan 8, 2024
Senate · Passed
Senate Vote: pass (21-0)
senate
Jan 5, 2024
Committee
REFERRED TO RULES
upper
1 primary · 0 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
NB
Neil Breslin
DDemocratic/Working Families
NY
46